Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific

Isavuconazole is the only US FDA-approved antifungal for treating invasive mucormycosis. We evaluated isavuconazole activity against a global collection of Mucorales isolates. Fifty-two isolates were collected during 2017–2020 from hospitals located in the USA, Europe, and the Asia-Pacific. Isolates...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalhaes, Cecilia G., Rhomberg, Paul R., Huband, Michael D., Pfaller, Michael A., Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960003/
https://www.ncbi.nlm.nih.gov/pubmed/36836355
http://dx.doi.org/10.3390/jof9020241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960003/
https://www.ncbi.nlm.nih.gov/pubmed/36836355
http://dx.doi.org/10.3390/jof9020241

Ejemplares similares